Dr. Reddy’s Laboratories Limited has informed the Exchange about press release dated 16-Dec-2022 titled Aurigene Oncology Limited,, a wholly owned subsidiary of the Company, reports results of AUR101 in Phase II……
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
